Capital, M&A & Industry Strategy

Generate Bio drops as data accidentally leaked ahead of European conference

Published

on

Phase 1 data from Generate Biomedicines’ ongoing chronic obstructive pulmonary disease study demonstrated “rapid and sustained reductions” across four disease biomarkers.​ 

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version